Interference with p53 protein inhibits hematopoietic and muscle differentiation

被引:115
作者
Soddu, S
Blandino, G
Scardigli, R
Coen, S
Marchetti, A
Rizzo, MG
Bossi, G
Cimino, L
Crescenzi, M
Sacchi, A
机构
[1] Molecular Oncogenesis Laboratory, Regina Elena Cancer Institute, Centro Ricerca Sperimentale
[2] Molecular Oncogenesis Laboratory, Regina Elena Cancer Institute, CRS, 00158 Rome
[3] Department of Molecular Cell Biology, Weizmann Institute, Rehovot
关键词
D O I
10.1083/jcb.134.1.193
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The involvement of p53 protein in cell differentiation has been recently suggested by some observations made with tumor cells and the correlation found between differentiation and increased levels of p53. However, the effect of p53 on differentiation is in apparent contrast with the normal development of p53-null mice. To test directly whether p53 has a function in cell differentiation, we interfered with the endogenous wt-p53 protein of nontransformed cells of two different murine histotypes: 32D myeloid progenitors, and C2C12 myoblasts. A drastic inhibition of terminal differentiation into granulocytes or myotubes, respectively, was observed upon expression of dominant-negative p53 proteins. This inhibition did not alter the cell cycle withdrawal typical of terminal differentiation, nor p21((WAF1/CIP1)) upregulation, indicating that interference with endogenous p53 directly affects cell differentiation, independently of the p53 activity on the cell cycle. We also found that the endogenous wt-p53 protein of C2C12 cells becomes transcriptionally active during myogenesis, and this activity is inhibited by p53 dominant-negative expression. Moreover, we found that p53 DNA-binding and transcriptional activities are both required to induce differentiation in p53-negative K562 cells. Taken together, these data strongly indicate that p53 is a regulator of cell differentiation and it exerts this role, at least in part, through its transcriptional activity.
引用
收藏
页码:193 / 204
页数:12
相关论文
共 72 条
[21]   P53-DEPENDENT INHIBITION OF CYCLIN-DEPENDENT KINASE-ACTIVITIES IN HUMAN FIBROBLASTS DURING RADIATION-INDUCED G1 ARREST [J].
DULIC, V ;
KAUFMANN, WK ;
WILSON, SJ ;
TLSTY, TD ;
LEES, E ;
HARPER, JW ;
ELLEDGE, SJ ;
REED, SI .
CELL, 1994, 76 (06) :1013-1023
[22]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[23]   WILD-TYPE P53 ACTIVATES TRANSCRIPTION INVITRO [J].
FARMER, G ;
BARGONETTI, J ;
ZHU, H ;
FRIEDMAN, P ;
PRYWES, R ;
PRIVES, C .
NATURE, 1992, 358 (6381) :83-86
[24]   DNA STRAND BREAKS AND ADP-RIBOSYL TRANSFERASE ACTIVATION DURING CELL-DIFFERENTIATION [J].
FARZANEH, F ;
ZALIN, R ;
BRILL, D ;
SHALL, S .
NATURE, 1982, 300 (5890) :362-366
[25]  
FEINSTEIN E, 1992, ONCOGENE, V7, P1853
[26]   THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION [J].
FINLAY, CA ;
HINDS, PW ;
LEVINE, AJ .
CELL, 1989, 57 (07) :1083-1093
[27]   ACTIVATING MUTATIONS IN P53 PRODUCE A COMMON CONFORMATIONAL EFFECT - A MONOCLONAL-ANTIBODY SPECIFIC FOR THE MUTANT FORM [J].
GANNON, JV ;
GREAVES, R ;
IGGO, R ;
LANE, DP .
EMBO JOURNAL, 1990, 9 (05) :1595-1602
[28]   DOWN-REGULATION OF WILD-TYPE P53 ACTIVITY INTERFERES WITH APOPTOSIS OF IL-3-DEPENDENT HEMATOPOIETIC-CELLS FOLLOWING IL-3 WITHDRAWAL [J].
GOTTLIEB, E ;
HAFFNER, R ;
VONRUDEN, T ;
WAGNER, EF ;
OREN, M .
EMBO JOURNAL, 1994, 13 (06) :1368-1374
[29]  
GREENBERGER JS, 1983, FED PROC, V42, P2762
[30]   DEMONSTRATION OF PERMANENT FACTOR-DEPENDENT MULTIPOTENTIAL (ERYTHROID-NEUTROPHIL-BASOPHIL) HEMATOPOIETIC PROGENITOR-CELL LINES [J].
GREENBERGER, JS ;
SAKAKEENY, MA ;
HUMPHRIES, RK ;
EAVES, CJ ;
ECKNER, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (10) :2931-2935